ALISO VIEJO, CA--(Marketwire - Jun 11, 2012) - Enclarity, Inc., a leading healthcare information solutions company, will present "Data Validation Strategies to Ensure the Integrity of HCP Data" at CBI's 8th Annual Medical Device and Diagnostics Compliance Congress at 11 a.m. on Thursday, June 14, 2012. The conference will be held at the Hyatt Regency Washington Hotel in Washington, D.C.
"The medical device and diagnostics industry continues to face a lot of guesswork on how to ensure the compliance of interactions with healthcare professionals (HCPs)," said Josh Schoeller, vice president of solutions architecture, Enclarity. "There is a growing risk of individual as well as corporate liability. Today, companies must improve compliance processes and strategies to meet evolving standards for an active corporate compliance program. Our role is to help medical device leaders emphasize the accuracy of HCP data for their aggregate spend programs. With such a large volume of information constantly being input and updated, ensuring the data is accurate and validated is a key challenge."
Schoeller will lead the discussion and explore best practices related to the validation of HCP data, including:
- Common challenges faced when validating HCP data
- Conceptual model for ensuring data accuracy
- Key takeaways from industry case studies
About Enclarity, Inc.
Enclarity solves healthcare's provider information problem by compiling the largest, most accurate and current medical provider database. Five of the top 15 pharmaceutical companies, seven of the 10 largest health insurance plans, four of the 10 largest preferred provider organizations and the two largest medical device manufacturers count on Enclarity. Its solutions improve claims processing, provider directories, regulatory compliance and marketing optimization. For more information, visit www.enclarity.com.